Compared to rosmanol-treated and carnosol-treated groups, the serum levels of TNF-α, IL-6, and MCP-1 in the combination-treated mice were all significantly reduced (Figure 5), indicating that rosmanol and carnosol could synergistically alleviate RA via inhibiting the inflammation response. The gene discussed is CCL2; the disease is rheumatoid arthritis.